BR9914158A - Composição antibiótica para o tratamento dos olhos, ouvidos e nariz - Google Patents

Composição antibiótica para o tratamento dos olhos, ouvidos e nariz

Info

Publication number
BR9914158A
BR9914158A BR9914158-2A BR9914158A BR9914158A BR 9914158 A BR9914158 A BR 9914158A BR 9914158 A BR9914158 A BR 9914158A BR 9914158 A BR9914158 A BR 9914158A
Authority
BR
Brazil
Prior art keywords
treatment
ears
nose
eyes
compositions
Prior art date
Application number
BR9914158-2A
Other languages
English (en)
Inventor
Gerald Cagle
Robert L Abshire
David W Stroman
John M Yanni
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of BR9914158A publication Critical patent/BR9914158A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçãO ANTIBIóTICA PARA O TRATAMENTO DOS OLHOS, OUVIDOS E NARIZ"<D>. São descritas composiçõers oftálmicas, óticas e nasais que contêm uma nova classe de antibióticos (por exemplo, moxifloxacina). As composições também contêm de preferência um ou mais agentes antinflamatórios. As composições podem ser utilizadas para o tratamento de condições oftálmicas, óticas ou nasais pela aplicação de forma tópica das composições aos tecidos afetados.
BR9914158-2A 1998-09-30 1999-09-29 Composição antibiótica para o tratamento dos olhos, ouvidos e nariz BR9914158A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10251098P 1998-09-30 1998-09-30
US10251198P 1998-09-30 1998-09-30
PCT/US1999/022625 WO2000018404A1 (en) 1998-09-30 1999-09-29 Antibiotic compositions for treatment of the eye, ear and nose

Publications (1)

Publication Number Publication Date
BR9914158A true BR9914158A (pt) 2001-06-26

Family

ID=26799456

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914158-2A BR9914158A (pt) 1998-09-30 1999-09-29 Composição antibiótica para o tratamento dos olhos, ouvidos e nariz

Country Status (7)

Country Link
EP (1) EP1117406A1 (pt)
JP (1) JP2002525326A (pt)
AU (1) AU6275999A (pt)
BR (1) BR9914158A (pt)
CA (1) CA2344050A1 (pt)
HK (1) HK1038692A1 (pt)
WO (1) WO2000018404A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
TR200200737T2 (tr) 1999-09-24 2002-08-21 Alcon, Inc. Siproflaksasin ve deksametazon içeren lokal süspansiyon formülasyonları
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
AU2005202737B2 (en) * 1999-12-22 2009-01-22 Bayer Innovation Gmbh Use of chemotherapeutic agents
DE19962353A1 (de) 1999-12-23 2001-07-05 Henkel Ecolab Gmbh & Co Ohg Hepatitis A Viruzid
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
AU2001276928A1 (en) 2000-07-26 2002-02-05 Alcon Universal Ltd. Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
DK1429780T3 (da) 2001-09-21 2006-02-13 Fremgangsmåde til behandling af mellemoreinfektioner
WO2003050107A1 (en) * 2001-12-13 2003-06-19 Wockhardt Limited New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
WO2003099815A1 (en) 2002-05-28 2003-12-04 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
AU2003296378A1 (en) * 2002-12-06 2004-06-30 Arriva Pharmaceuticals, Inc. Methods and compositions for treatment of otitis media
CA2537066C (en) 2003-09-04 2011-05-24 Wockhardt Limited Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
US20090042936A1 (en) * 2007-08-10 2009-02-12 Ward Keith W Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
WO2012177251A1 (en) * 2011-06-22 2012-12-27 Adeda Therapeutics Company Limited Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
JP2549285B2 (ja) * 1987-02-02 1996-10-30 第一製薬株式会社 鼻用噴霧剤
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
WO1990001933A1 (en) * 1988-08-26 1990-03-08 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
MX9701731A (es) * 1995-06-06 1997-10-31 Bayer Ag Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido.
JPH10130148A (ja) * 1996-09-04 1998-05-19 Senju Pharmaceut Co Ltd ネブライザー用組成物

Also Published As

Publication number Publication date
CA2344050A1 (en) 2000-04-06
HK1038692A1 (zh) 2002-03-28
JP2002525326A (ja) 2002-08-13
EP1117406A1 (en) 2001-07-25
AU6275999A (en) 2000-04-17
WO2000018404A1 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
BR9914109A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
BR9914158A (pt) Composição antibiótica para o tratamento dos olhos, ouvidos e nariz
BR9914151A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
BR0208489A (pt) Derivados de n-(arilsulfonil) beta-aminoácidos, comportando um grupo aminoetilado substituìdo, o respectivo processo de preparação e as composições farmacêuticas que os contêm
AU2275397A (en) Troponin subunits and fragments useful as angiogenesis inhibitors
BR9914696A (pt) Composto, processo para tratamento de distúrbio mediado por ciclo-oxigenase-2 em um indivìduo, e, composição farmacêutica
BRPI9710372B8 (pt) composto, e, composição farmacêutica.
BR9814118A (pt) Nova composição de matéria
BR9913255A (pt) Composto, composição farmacêutica, processo de tratamento de uma condição de doença mediada por metaloproteinase, processo para preparar um composto, e, uso de um composto
BR9706629A (pt) Montagem de roda e pneu
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
BR0014078A (pt) Inibidores de fator xa
TR199800019T1 (xx) Trombosit topaklanmas�n� �nleyici yeni maddeler.
BR9914044A (pt) ésteres tetrahidropirido
BR9811099A (pt) Inibidores de urocinase
BR9809022A (pt) Composições antiinflamatórias nasais tópicas
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
BR0109602A (pt) Glóbulos de liberação controlada contendo estavudina
PT952974E (pt) Derivados bifenilicos substituidos por um radical aromatico ou heteroaromatico e composicoes farmaceuticas e cosmeticas que os contem
BR0012696A (pt) Composição oftálmica

Legal Events

Date Code Title Description
B08E Application fees: requirement for complementation of annuity fee

Free format text: COMPLEMENTAR A 3A E 4A ANUIDADES DE ACORDO COM A TABELA VIGENTE, REFERENTE AS GUIAS 300226905046 E300232673143 RESPECTIVAMENTE E COMPROVAR O RECOLHIMENTO DA 5A, 6A, 7A E 8A ANUIDADES.

B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AO NAO CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 1929 DE 26/12/2007.

B08E Application fees: requirement for complementation of annuity fee

Free format text: COMPLEMENTAR A 3A E 4A ANUIDADES DE ACORDO COM A TABELA VIGENTE, REFERENTE A GUIA 300226905046 E 300230673143, E COMPROVAR O RECOLHIMENTO DA 5A,6A, 7A,8A,9A ANUIDADES

B08H Application fees: decision cancelled

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1961 DE 05/08/2008 POR TER SIDO INDEVIDO.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1960 DE 29/07/2008.